Academic Journal
Should Ki-67 be adopted to select breast cancer patients for treatment with adjuvant abemaciclib?
العنوان: | Should Ki-67 be adopted to select breast cancer patients for treatment with adjuvant abemaciclib? |
---|---|
المؤلفون: | Tarantino, P., Burstein, H.J., Lin, N.U., Krop, I.E., Winer, E.P., Schnitt, S.J., Hamilton, E.P., Hurvitz, S.A., Rugo, H.S., Curigliano, G., Tolaney, S.M. |
المصدر: | Annals of Oncology ; volume 33, issue 3, page 234-238 ; ISSN 0923-7534 |
بيانات النشر: | Elsevier BV |
سنة النشر: | 2022 |
المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
DOI: | 10.1016/j.annonc.2021.12.004 |
الاتاحة: | http://dx.doi.org/10.1016/j.annonc.2021.12.004 https://api.elsevier.com/content/article/PII:S0923753421048778?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S0923753421048778?httpAccept=text/plain |
Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/ |
رقم الانضمام: | edsbas.C7E821B1 |
قاعدة البيانات: | BASE |
DOI: | 10.1016/j.annonc.2021.12.004 |
---|